Details for Patent: 7,569,612
✉ Email this page to a colleague
Which drugs does patent 7,569,612 protect, and when does it expire?
Patent 7,569,612 protects FIBRICOR and is included in one NDA.
Summary for Patent: 7,569,612
Title: | Methods of use of fenofibric acid |
Abstract: | Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. Dosage forms include, for example, immediate-release dosage forms. |
Inventor(s): | Arnold; Kristin Anne (Morrisville, PA), Feng; Hengsheng (Cherry Hill, NJ) |
Assignee: | Mutual Pharmaceutical Company, Inc. (Philadelphia, PA) |
Application Number: | 12/141,377 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 7,569,612
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-001 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS | ⤷ Sign Up | ||||
Athena | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |